
Screening for lung cancer in NZ is highly unlikely to be cost-effective: New NZ study - Public Health Expert
Public Health Expert • Sep 03, 2018 •
Dr Richard Jaine, Dr Giorgi Kvizhinadze, Prof Nick Wilson, Prof Tony Blakely There is reasonably strong evidence screening for lung cancer with low-dose computed tomography (LDCT) scans is effective at reducing lung cancer mortality. However, new research suggests it is highly unlikely to be cost-effective in NZ. We have just published the first NZ study to examine the cost-effectiveness of … Read More